# Explore the Synergy of Combination TKI Therapy

> **NCT02129166** · PHASE1 · WITHDRAWN · sponsor: **University of Florida**

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Dasatinib
- **DRUG:** Dasatinib+Imatinib

## Key facts

- **NCT ID:** NCT02129166
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-09
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI resigned
- **Last updated:** 2014-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02129166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02129166, "Explore the Synergy of Combination TKI Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02129166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*